Search Results - "LIU, Jeff C"

Refine Results
  1. 1

    Generation of Functional Liver Sinusoidal Endothelial Cells from Human Pluripotent Stem-Cell-Derived Venous Angioblasts by Gage, Blair K., Liu, Jeff C., Innes, Brendan T., MacParland, Sonya A., McGilvray, Ian D., Bader, Gary D., Keller, Gordon M.

    Published in Cell stem cell (06-08-2020)
    “…Liver sinusoidal endothelial cells (LSECs) form a highly specialized microvasculature that plays a critical role in liver function and disease. To better…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4

    Mitochondrial OXPHOS Induced by RB1 Deficiency in Breast Cancer: Implications for Anabolic Metabolism, Stemness, and Metastasis by Zacksenhaus, Eldad, Shrestha, Mariusz, Liu, Jeff C, Vorobieva, Ioulia, Chung, Philip E D, Ju, YoungJun, Nir, Uri, Jiang, Zhe

    Published in Trends in cancer (01-11-2017)
    “…A switch from catabolic to anabolic metabolism, a major hallmark of cancer, enables rapid cell duplication, and is driven by multiple oncogenic alterations,…”
    Get more information
    Journal Article
  5. 5

    RB1 status in triple negative breast cancer cells dictates response to radiation treatment and selective therapeutic drugs by Robinson, Tyler J W, Liu, Jeff C, Vizeacoumar, Frederick, Sun, Thomas, Maclean, Neil, Egan, Sean E, Schimmer, Aaron D, Datti, Alessandro, Zacksenhaus, Eldad

    Published in PloS one (12-11-2013)
    “…Triple negative breast cancer (TNBC) includes basal-like and claudin-low subtypes for which only chemotherapy and radiation therapy are currently available…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Rb deletion in mouse mammary progenitors induces luminal-B or basal-like/EMT tumor subtypes depending on p53 status by Jiang, Zhe, Deng, Tao, Jones, Robert, Li, Huiqin, Herschkowitz, Jason I, Liu, Jeff C, Weigman, Victor J, Tsao, Ming-Sound, Lane, Timothy F, Perou, Charles M, Zacksenhaus, Eldad

    Published in The Journal of clinical investigation (01-09-2010)
    “…Breast cancer is a highly heterogeneous disease, with several different subtypes being characterized by distinct histology, gene expression patterns, and…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10

    Identification of tumorsphere- and tumor-initiating cells in HER2/Neu-induced mammary tumors by Liu, Jeff C, Deng, Tao, Lehal, Rajwinder S, Kim, Jinny, Zacksenhaus, Eldad

    Published in Cancer research (Chicago, Ill.) (15-09-2007)
    “…A variety of human malignancies, including breast cancer, are thought to be organized in a hierarchy, whereby a relatively minor population of tumor initiating…”
    Get full text
    Journal Article
  11. 11

    Combined deletion of Pten and p53 in mammary epithelium accelerates triple‐negative breast cancer with dependency on eEF2K by Liu, Jeff C, Voisin, Veronique, Wang, Sharon, Wang, Dong‐Yu, Jones, Robert A, Datti, Alessandro, Uehling, David, Al‐awar, Rima, Egan, Sean E, Bader, Gary D, Tsao, Ming, Mak, Tak W, Zacksenhaus, Eldad

    Published in EMBO molecular medicine (01-12-2014)
    “…The tumor suppressors Pten and p53 are frequently lost in breast cancer, yet the consequences of their combined inactivation are poorly understood. Here, we…”
    Get full text
    Journal Article
  12. 12

    Cooperation between Pik3ca and p53 Mutations in Mouse Mammary Tumor Formation by ADAMS, Jessica R, KELI XU, EGAN, Sean E, LIU, Jeff C, RUIZ AGAMEZ, Natalia M, LOCH, Amanda J, WONG, Ruth G, WEI WANG, WRIGHT, Katherine L, LANE, Timothy F, ZACKSENHAUS, Eldad

    Published in Cancer research (Chicago, Ill.) (01-04-2011)
    “…PIK3CA, which codes for the p110α catalytic subunit of phosphatidylinositol 3-kinase, is one of the most frequently mutated genes in human breast cancer. Here,…”
    Get full text
    Journal Article
  13. 13
  14. 14

    RB1 and p53 at the crossroad of EMT and triple-negative breast cancer by Jiang, Zhe, Jones, Robert, Liu, Jeff C., Deng, Tao, Robinson, Tyler, Chung, Philip E.D., Wang, Sharon, Herschkowitz, Jason I., Egan, Sean E., Perou, Charles M., Zacksenhaus, Eldad

    Published in Cell cycle (Georgetown, Tex.) (15-05-2011)
    “…Triple-negative breast cancer (TNBC) is a heterogeneous disease that includes Basal-like and Claudin-low tumors. The Claudin-low tumors are enriched for…”
    Get full text
    Journal Article
  15. 15

    CDC25 as a common therapeutic target for triple-negative breast cancer - the challenges ahead by Zacksenhaus, Eldad, Liu, Jeff C., Granieri, Letizia, Vorobieva, Ioulia, Wang, Dong-Yu, Ghanbari-Azarnier, Ronak, Li, Huiqin, Ali, Amjad, Chung, Philip E.D., Ju, YoungJun, Jiang, Zhe, Shrestha, Mariusz

    Published in Molecular & cellular oncology (04-07-2018)
    “…The dual phosphatase CDC25 has recently been identified as a target for diverse triple-negative breast cancers including RB1/PTEN/P53-deficient tumors…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Preferential Killing of Breast Tumor Initiating Cells by N,N-Diethyl-2-[4-(Phenylmethyl)Phenoxy]Ethanamine/Tesmilifene by Deng, Tao, Liu, Jeff C, Pritchard, Kathleen I, Eisen, Andrea, Zacksenhaus, Eldad

    Published in Clinical cancer research (01-01-2009)
    “…Purpose: N,N -Diethyl-2-[4-(phenylmethyl)phenoxy]ethanamine (DPPE; tesmilifene) is thought to potentiate the antineoplastic effect of cytotoxic drugs. In a…”
    Get full text
    Journal Article
  18. 18

    Targeted Pten deletion plus p53-R270H mutation in mouse mammary epithelium induces aggressive claudin-low and basal-like breast cancer by Wang, Sharon, Liu, Jeff C, Kim, Danbi, Datti, Alessandro, Zacksenhaus, Eldad

    Published in Breast cancer research : BCR (19-01-2016)
    “…Triple-negative breast cancer (TNBC), an aggressive disease comprising several subtypes including basal-like and claudin-low, involves frequent deletions or…”
    Get full text
    Journal Article
  19. 19
  20. 20